References

1. BHIVA. Guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2025
interim update). Available from: https://bhiva.org/wp-content/uploads/2025/10/BHIVA-guidelines-on-antiretroviral-treatment-for-adults-living-with-HIV-1-2025-interim-update.pdf

2. BHIVA. Guidelines on the management of HIV in pregnancy and the postpartum period. Available from: https://bhiva.org/wp-content/uploads/2025/06/BHIVA-guidelines-on-the-management-of-HIV-in-pregnancy-and-the-postpartum-period.pdf

3. BHIVA. Standards of Care for People Living with HIV 2018. Available from: https://bhiva.org/standards-of-care-2018/

4. Emtricitabine/Tenofovir Disoproxil Mylan 200 mg/245 mg Film-coated Tablets. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/9028/smpc

5. EACS guidelines. Initial regimens: ART-naive adults. Avaiable from: https://eacs.sanfordguide.com/en/eacs-hiv/art/eacs-initial-regimens-arv-naive-adults

6. Vocabria 600 mg prolonged-release suspension for injection. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/12957/smpc

7. Rekambys 900 mg prolonged-release suspension for injection. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/12950/smpc

8. HIV Pharmacy Association.  Patient Information Leaflets. Available from: https://hivpa.org/patient-information-leaflets-pils/

9. European Medicines Agency. Questions and answers on generic medicines 2012. Available from: https://www.ema.europa.eu/en/documents/other/questions-and-answers-generic-medicines_en.pdf